Vyvanse is not FDA-approved to treat ADHD rein a child younger than 6 years old. Vyvanse is not FDA-approved to treat binge eating disorder in anyone younger than 18 years old. Lisdexamfetamine dimesylate had no apparent effects on embryo-fetal morphological development or survival when administered orally to pregnant rats and rabbits throughout